Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258